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Changes in cause-specific mortality among the elderly  
in Canada, 1979–2011
Marie-Pier Bergeron-Boucher1
Robert Bourbeau
Jacques Légaré
Abstract
The structure of  causes of  death in Canada has been changing since the onset of  the “cardiovascular revolu-
tion.” While mortality due to cardiovascular diseases has been declining, mortality due to other causes of  death, 
such as cancers and Alzheimer’s disease has been increasing. Our research investigates how these changes have 
re-modeled life expectancy at age 65 and age 85, and what specific causes of  death are involved. We distinguish 
between premature and senescent deaths in Canada, using a cause-specific age structure. Our results suggest 
that although a decline in premature deaths has contributed to increasing life expectancy in recent years, most 
of  the gains in life expectancy at age 65 and 85 have resulted from a decline in senescent deaths. We also find a 
decline in mortality due to the main causes of  death, leading to a greater diversification of  causes.
Keywords: Causes of  death, life expectancy, age patterns of  mortality, Canada, decomposition.
Résumé
Depuis le début de la révolution cardiovasculaire, le Canada a connu d’importants changements dans la distri-
bution des décès selon la cause. La mortalité par maladies cardiovasculaires a connu une importante diminu-
tion alors que les taux de mortalité pour les cancers et pour la maladie d’Alzheimer ont augmenté. Cet article 
examine comment ces changements ont influencé les tendances de l’espérance de vie à 65 et à 85 ans et quelles 
causes de décès spécifiques furent impliquées. Une distinction entre les décès prématurés et les décès liés à un 
processus de sénescence est réalisée, se basant sur deux indicateurs de variations par âge des causes de décès. 
Nos résultats suggèrent que la majorité des gains en espérance de vie à 65 et 85 ans proviennent d’une plus 
faible mortalité par cause de décès sénescente. De plus, une diminution des principales causes de décès chez 
les personnes âgées de 65 ans et plus laisse place à une plus grande diversification de causes aux grands âges. 
Mots-clés : Causes de décès, espérance de vie, variations par âge, Canada, décomposition.
Background
Life expectancy has undergone an important increase over the last 170 years in many industrialized coun-
tries (Oeppen and Vaupel 2002). Changes in age and cause of  death structures of  mortality account for this 
development. The epidemiological transition, as formulated by Omran (1971), summarizes these changes. The 
epidemiological transition involves a shift from a high to a low stable level of  mortality, in which degenerative 
and man-made diseases replace infectious diseases as the main causes of  death (Omran 1971). It also involves an 
important transformation of  the age structure of  mortality, i.e., the average age at death shifts from young ages 
toward older ages. The epidemiological transition was observed in many industrialized countries until the 1970s 
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(Meslé and Vallin 2000). However, in most of  these countries, mortality levels from degenerative and man-made 
diseases did not stabilize, as suggested by Omran (1971), but a further decline in mortality due to cardiovascular 
diseases was observed (Meslé and Vallin 2000). These changes in the structure of  causes of  death have resulted 
in a further increase in life expectancy for many industrialized countries. 
Between 1921 and 2011, life expectancy at birth in Canada increased from 56.0 to 79.5 years for males and 
from 58.2 to 83.7 for females (CHMD 2015). Progress in life expectancy at birth was initially driven by a reduc-
tion in infant mortality. However, since the middle of  the twentieth century, most of  this increase has resulted 
from mortality reduction at higher ages (Decady and Greenberg 2014). These changes have enabled life expect-
ancy at birth to keep rising, but have also caused life expectancy at higher ages to increase over time (Vallin and 
Meslé 2010). For example, between 1950 and 2011, life expectancy at age 65 in Canada increased from 13.3 to 
18.9 years for males and from 15.0 to 21.8 for females (CHMD 2015). 
Reductions in cause-specific mortality occurring at higher ages, as in the case of  cardiovascular diseases, 
have been the main drivers of  life expectancy increase in Canada since the 1950s (Decady and Greenberg 2014). 
Death rates from heart and cerebrovascular diseases decreased by 37.4 and 39.2 per cent, respectively, between 
1981 and 2007 (Milan 2011). However, mortality due to other causes of  death rose over the same period. Mor-
tality due to cancers increased until the middle of  the 1990s but has since begun to decrease. An increase in 
mortality due to diabetes and Alzheimer’s disease has also been observed (Milan 2011). However, less is known 
about how these changes have influenced Canadian life expectancy trends, and how the cause of  death structure 
has changed since the cardiovascular revolution. 
Decady and Greenberg (2014) state that most of  the progress in life expectancy in Canada in the past 90 
years has come from a decline in premature deaths. Premature deaths are defined by the authors as deaths occur-
ring among individuals aged less than 75 years. Other indicators of  premature deaths are also often used, such 
as potential years of  life lost (PYLL), which also uses a cutoff  age (e.g., 70 or 75) under which a person’s death 
will be considered premature (OECD 2016). The concept of  premature deaths refers to deaths occurring at 
younger ages, which are before their time and could, a priori, have been preventable. Premature deaths are often 
contrasted with senescent deaths, which tend to result from a more natural aging process and to occur at older ages 
(Brody and Schneider 1986; Horiuchi 2007). Senescent mortality here refers to the increase over age in the risk 
of  dying, resulting from gradual physical deterioration with age (Bongaarts 2005; Vaupel 2010).
Instead of  defining premature deaths as deaths occurring before a fixed age, some authors have preferred 
to look at the age structure of  cause-specific mortality (Brody and Schneider 1986; Horiuchi 2007; Horiuchi and 
Wilmoth 1997). Causes of  death have their own specific age structure: some tend to occur during childhood, 
others around middle age, and some at older ages. The age structure of  causes of  death reveals information 
about physiological and biological changes with age, but also about individual differences in longevity (Horiuchi 
2007). Age-variation analyses of  causes of  death have also been useful in understanding how diseases develop: 
some diseases have been shown to develop prematurely and selectively among certain individuals, whereas others 
appear at old or very old ages and may reflect a senescence process (Brody and Schneider 1986; Horiuchi 2007). 
Our research aims to analyze changes in causes of  death at age 65 and older in Canada since 1979 via three 
objectives. We first look at changes in life expectancy trends at ages 65 and 85 years. Given these changes in 
life expectancy trends, we determine different historical time periods and calculate, for each of  these periods, 
the age- and cause-specific contribution to life expectancy increase, in order to evaluate emergent and declining 
causes of  death and their impact on general mortality. Finally, we establish age variation patterns of  causes of  
death, to distinguish between premature and senescent causes of  death in Canada.
Data
Data on causes of  death are taken from the Canadian Vital Statistics from 1979 to 1999, provided by Statis-
tics Canada, which publishes causes of  death data after collating and grouping information from the provinces 
and territories where data are collected. Causes of  death data from 2000 to 2011 were extracted from CANSIM 
tables published by Statistics Canada (Statistics Canada 2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 2015g). The 
Bergeron-Boucher, Bourbeau, and Légaré: Cause-specific mortality among the elderly
217
data are available for 5-year age groups, with the last available age-group being 90 years and older (90+). The data 
on population and exposure to risk were extracted from the Canadian Human Mortality Database (CHMD), 
which provides historical data based on population surveys and censuses in Canada (CHMD 2015). 
Deaths are classified according to the International Classification of  Diseases (ICD), which has changed 
over the years. In the period from 1979 to 2011, the ICD was changed only once in Canada, in 2000, from ICD-
9 (WHO 1977) to ICD-10 (WHO 2010). However, this change was one of  the most major that the ICD has 
undergone, leading to important discontinuities in some causes of  death time-series, e.g., those for pneumonia 
and Alzheimer’s disease (Geran et al. 2005; Meslé and Vallin 2008). To avoid such discontinuities, data on causes 
of  death before 1999 and after 2000 are analyzed as two different series.
The ten main causes of  death at age 65 and older in Canada are selected (Table 1). In 2011, these causes 
represented 75.7 per cent of  all deaths at age 65 and older. Neoplasms are divided into five subgroups of  causes: 
cancers of  the lung, bronchitis and trachea (LBT), colon and rectum (CR), breast, prostate, and other cancers.
Table 1. ICD-9 and ICD-10 codes for the selected causes of death and their proportions (%) 
at age 65 years and older in 1979, 1995, and 2011, Canada
Causes of death ICD-9 ICD-10 % 1979 % 1995 % 2011
1 Malignant neoplasms 140–208 C00–C97 21.4 25.4 27.8
Lung, bronchitis, and trachea cancer 162 C33–C34 4.4 6.5 7.4
Colon and rectum cancer 153–154 C18–C21 3.2 2.9 3.3
Breast cancer 174–175 C50 1.4 1.8 1.6
Prostate cancer 185 C61 1.7 2.2 1.8
Other cancers 140–152;
155–161;
163–173;
176–184;
186–208
C00–C17;
C22– C32;
C35–C49;
C51–C60;
C62–C97
10.7 12.0 13.7
2 Heart diseases 390–398;
402; 404;
410–429
I00–I09;
I11; I13;
I20–I51
40.2 30.6 21.3
3 Cerebrovascular diseases 430–438 I60–I69 11.8 8.8 6.3
4 Chronic lower respiratory diseases 490–94;  496 J40–J47 3.4 5.2 5.4
5 Diabetes mellitus 250 E10–E14 2.0 2.8 3.1
6 Alzheimer’s disease 331.0 G30 0.0 1.7 3.3
7 Influenza and pneumonia 480–487 J10–J18 3.3 4.3 2.7
8 Accidents E800–E869;
E880–E929
V01–X59;
Y85–Y86
2.4 2.1 3.2
9 Nephritis, nephrotic syndrome
and nephropathy
580–589 N00–N07;
N17–N19;
N25–27
1.0 1.4 1.6
10 Parkinson’s diseases 332 G20–G21 0.3 0.7 1.0
11 Other diseases – – 14.2 17.0 24.3
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 
2015f, 2015g), and Geran et al. (2005).
Methods
Changes in life expectancy at ages 65 and 85 years: Segmented regression
To evaluate changes in life expectancy trends, a segmented regression methodology is used. The segmented 
regression method was introduced by Muggeo (2003) and applied in the life expectancy context by Camarda et 
al. (2012). This method aims to find the slopes and breakpoints of  a piecewise linear regression, formed of  two 
or more linear segments connected at unknown values (Camarda et al. 2012). Ouellette et al. (2014) also used 
this method to find discontinuities in general, and in age-and cause-specific mortality trends. When there is only 
one breakpoint, the method corresponds to:
ex(t) = αx + β
1
x t + β
2
x (t − ψx  )
+,
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where ex(t) is the life expectancy at age x and year t, β1x is the slope of  the first segment, β2x is the difference 
between the slope of  the first and the second segment, and ψx is the breakpoint. Then, (t − ψx )
+ = (t − ψx  )* 
I (t > ψx  ), where I is an indicator function equal to 1 when the year t is higher than the breakpoint year (t > ψx  ) 
(Camarda et al. 2012).
Contribution to changes in life expectancies
Evaluation of  age and cause of  death contributions to changes in life expectancy is done using standard 
decomposition methods (Arriaga 1984; Preston et al. 2001). The contributions are calculated for different 
periods, based on the breakpoints resulting from the segmented regression. 
Age variation
The age profile of  each cause of  death is based on two indicators. The first is the proportion between age 
x and x+n of  cause i, n pix(t), calculated as
n p
i
x(t) = nD 
i
x(t) / nDx(t),
where nDx(t) and nDix(t) are the total and cause i number of  observed deaths between ages x and x+n for year t, 
respectively. This indicator shows the relative importance of  causes of  death at specific ages (Horiuchi 2007). 
The second indicator is the life table aging rate (LAR). The LAR is interpreted as the slope of  an exponential 
curve. Constant LARs through ages thus represent an exponential increase with age of  the death rates (Horiuchi 
and Wilmoth 1997). This indicator allows us to see whether and how the increase of  the death rates for a specific 
cause is accelerating or decelerating with age. The LAR for a cause of  death i at age x is estimated as
LARix(t) = [ln(nM 
i
x(t)) − ln(nM 
i
x−n
(t))] / n,
where nM ix(t) is the death rate of  cause i between ages x and x + n for year t. 
These indicators thus represent two different aspects of  causes of  death age variation: the proportions 
show the relative importance of  causes of  death at each age and the LARs show if  the risk of  dying from a 
specific cause of  death accelerates or decelerates with age, and whether it increases (positive LARs) or decreases 
(negative LARs). Both indicators are compared to validate each other’s results. 
Results
Breakpoints in life expectancy at ages 65 and 85 years
Life expectancy at age 65 and 85 years (e65 and e85) has undergone a major increase in Canada over the twen-
tieth century. However, Figure 1 shows that this progress has not been linear and a number of  different breaks in 
the trends can be observed. Three breakpoints in life expectancy at age 65 years for females were detected since 
1921 (1943, 1987, and 1998), but only two for males (1972 and 1998). For trends in life expectancy at age 85, 
there were three breakpoints for each sex: 1949, 1989, and 1998 for females and 1947, 1984, and 1999 for males. 
Before the first breakpoint, in the mid-1940s, progress in life expectancy at age 65 and 85 years was mod-
est. Based on the maximum life expectancy observed each year, Vallin and Meslé (2010) determined that the 
increase in life expectancy after the first breakpoint was the result of  the cardiovascular revolution. Reductions 
in cardiovascular mortality enabled life expectancy at higher ages to increase. In Canada, these progresses only 
became evident on e65 after 1972 for males. 
In the middle of  the 1980s, the rate of  increase in e65 for females and e85 for both sexes decelerated. For the 
first time, life expectancy for males began to increase faster than for females. Since 1998–99, life expectancies 
for both sexes and at both ages have increased at a faster pace than in any other observed period. In the next 
section, we present the age and cause contributions to these changes in life expectancy.
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Age and cause of  death contributions to changes in life expectancy
Based on the breakpoints identified in the previous section and the causes of  death data constraints, we 
determined three historical periods of  change: 1979–85, 1985–99, and 2000–11. In these three periods, life ex-
pectancy at age 65 increased, respectively, by 0.32, 0.88, and 1.59 years for females and by 0.29, 1.46, and 2.31 
years for males. 
Age contributions
Figure 2 shows the annualized age- and cause-specific contribution to changes in e65. For the period 1979–
85, 88 per cent (for males) and 51 per cent (for females) of  the changes in life expectancy at age 65 were the 
result of  lower mortality between ages 65 and 74 years. A large part of  the increase in life expectancy therefore 
came about because of  a decline in premature mortality, as defined by Decady and Greenberg (2014). However, 
these proportions decreased to 44 and 31 per cent, respectively, in 2000–11. Changes taking place at older ages 
are thus playing a greater role in the increase in life expectancy in recent years.
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Figure 1. Canadian life expectancy at ages 
65 and 85 years by sex, associated segmented 
regressions, and respective slopes, 1921–2011.
Sources: CHMD (2015) and authors’ own calculations.
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Cause contributions
Regardless of  the period, the increase in life expectancy at age 65 is mainly the result of  a decrease in mor-
tality due to cardiovascular diseases (CVD), which include heart and cerebrovascular diseases (Figure 2). For the 
period 1979–85, most of  the other selected causes contributed to reduce e65, especially cancers, chronic lower 
respiratory diseases, Alzheimer’s disease, and influenza and pneumonia.
Over the period 1985–99, the main causes of  death were now contributing positively, or made only very 
small negative contributions, to the e65 increase for males. However, the increase in life expectancy for females 
continued to be slowed down by lung, bronchitis, and trachea (LBT) cancer, chronic lower respiratory diseases 
(CLRD), Alzheimer’s disease, and the residual group of  causes. Females experienced a loss of  0.43 years in life 
expectancy due to these last four causes, while males gained 0.27 years as a result of  changes in those same 
causes (see Appendix A). These differences explain why female e65 increased less than that of  males during this 
period, together with a greater contribution from heart diseases for males. Smaller gains in cerebrovascular dis-
eases were also observed for both sexes over this same period. 
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Figure 2. Annualized age and causes of death contribution to the increase in Canadian life expectancy at age 65 
by sex, period 1979–85, 1985–99, and 2000–11.
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 2015g), CHMD (2015), and 
authors’ own calculations.
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In the period 2000–11, e65 for both sexes increased at a faster pace than in the previous periods. Most causes 
of  death were now showing positive or null gains in terms of  life expectancy, with the exception of  LBT cancer 
for females, and accidents and “other causes” at older ages for both sexes. Appendix B shows that the death 
rates at 65 years and older by cause of  death, with exception of  the three previously mentioned causes, have 
been decreasing or stayed approximately constant since 2000. 
Given the increasing importance of  older age-groups in life expectancy changes, we also looked at the 
cause-specific contributions to changes in e85. Appendix A shows similar results for the decomposition of  life 
expectancy at age 85 and age 65 years. The deceleration in the e85 trend observed between 1985 and 1999 (Figure 
1) is partially explained by a lower annualized gain in terms of  cerebrovascular diseases compared to the previ-
ous period, and by a negative contribution for most of  the other causes.
Age variation profile of  causes of  death
As suggested by Horiuchi (2007), we use the age of  85 years to separate “younger-old age” from “oldest-old 
age” mortality, when looking at the proportions by age. We distinguish between causes of  death that are more 
prevalent before (downward trends) or after (upward trends) age 85 (see Figures C1 and C2 in Appendix C). 
The age variation of  causes of  death using LARs shows that the increase in some cause-specific death rates 
decelerates (decreasing LARs) with age, while it accelerates (increasing LARs) for other causes (see Figures C3 
and C4 in Appendix C). The LARs even become negative after a certain age for some causes, meaning that the 
death rates are decreasing with age. Based on this indicator, we separate cause of  death LARs that decrease with 
age from those which stay constant or increase (see Appendix D for more details on the classification criteria). 
Table 2. Causes of death classified according to their age variation using proportions and life table aging 
rates (LARs), Canada, 1979–2011
Lower proportions before age 85
(Upward trends)
Higher proportions before age 85
(Downward trends)
Decreasing LAR Cerebrovascular diseases (Male)
Alzheimer’s disease
Lung, bronchitis and trachea cancer
Colon and rectum cancer (Male)
Prostate cancer
Other cancers
Chronic lower respiratory diseases
Diabetes mellitus
Parkinson’s disease
Constant or increasing LAR Heart diseases
Cerebrovascular diseases (Female)
Influenza and pneumonia
Accidents
Nephritis, nephrotic syndrome and 
nephropathy
Other diseases
Colon and rectum cancer (Female)
Breast cancer
According to these definitions, two main patterns of  causes can be distinguished, as shown in Table 2. The 
first pattern shows higher proportions before age 85 years and decreasing LARs over age. These causes have a 
higher relative importance at youngest-old ages than at oldest-old ages, and the risk of  dying from these causes 
decelerates or decreases with age. The decrease in the proportions and LARs with age could come from (1) a 
tendency of  these causes to develop early in life; and/or (2) other causes of  death tending to take over mortality 
at higher ages. This pattern is consistent with Horiuchi’s (2007) findings for the US White population, where this 
category represents causes of  death that tend to develop prematurely and selectively among certain individuals. 
They are also often associated with certain risk factors, such as smoking, diet, heredity, etc. 
The second pattern shows higher proportions after age 85 years, and increasing or constant LARs over age. 
These causes have a higher relative importance at the oldest-old ages, and the risk of  dying from them increases 
and often accelerates with age. Causes included in this group thus occur at older ages, and tend to be more asso-
ciated with a process of  senescence. As Horiuchi and Wilmoth (1997) also pointed out, competing risk among 
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causes of  death is more important after a certain age, so that as a result of  senescence, people become more 
susceptible to death from causes that develop more rapidly than from other causes which take longer to result 
in death. An example for males is given in Figure 3 for LBT cancer and for accidents, representing the two age 
patterns, respectively (see Appendix C for the other causes).
There are, however, some exceptions to these two patterns. Alzheimer’s and cerebrovascular diseases (male) 
have more importance at higher ages, although their LARs decrease with age. Breast cancer and CR cancer (fe-
male) have more importance at younger ages; however, their LARs do not decrease with age. These results may 
be due to inadequate classification criteria or specification of  the cause of  death, but more research would be 
needed to explain them fully. 
Using the classification of  deaths discussed earlier, in 1979 premature deaths represented about 21 and 30 
per cent of  total deaths at age 65 years and older for females and males, respectively, compared with 31 and 
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Figure 3. Age variation for Lung, bronchial, and trachea cancer and Accidents using 
proportions and life table aging rates (LARs), observed (dot) and smoothed (line), 
Males, Canada, 1979–2011 and age-specific average over time (in black).
Note: The trends are smoothed using a P-spline smoothing procedure for Poisson death counts (Camarda 
2012).
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 
2015g), CHMD (2015), and authors’ own calculations.
Bergeron-Boucher, Bourbeau, and Légaré: Cause-specific mortality among the elderly
223
41 per cent in 2011, including CR cancer deaths as premature deaths for females. This change in proportions 
may be a result of  the decline in deaths due to cardiovascular diseases, classified as senescent, and the increase 
in cancer deaths observed up to the beginning of  the 21st century. Between 1979 and 1985, premature deaths 
contributed to a loss of  0.17 years of  life expectancy at age 65 for females and 0.18 years for males. However, 
between 2000 and 2011 they contributed to increasing e65 by 0.20 and 0.75 years for females and males, respec-
tively, representing 13 and 32 per cent of  the total increase in that period.
These results point to some particular characteristics of  the Canadian population and of  the health condi-
tions in Canada. The main drivers of  the loss of  premature years in life expectancy at age 65 years in the period 
1979–85 were increases in mortality from lung, bronchitis, and trachea cancers and from chronic lower respira-
tory diseases (Appendix A). These two last causes of  death are highly influenced by tobacco consumption (CDC 
2016). A decline in smoking among the Canadian population could have enabled more of  these deaths to be 
prevented in more recent years, especially for males (CCSSC 2010).
However, changes in premature deaths have not been the main drivers of  mortality changes since 1979. 
Gains in life expectancy at age 65 years have mainly resulted from a decrease in senescent deaths, including 
heart diseases. Vaupel (2010) has argued that although senescence is inevitable for human populations, it can 
nonetheless be postponed, and this has been made possible by ongoing improvements in health care. It has led 
to declines in senescence-associated causes of  death, with the result that mortality decrease is observed at higher 
and higher ages.
Discussion 
In Canada, deaths classified as premature (first age pattern) represented about 26 per cent of  all deaths at 
age 65 and older in 1979 and about 36 per cent in 2011, for both sexes combined. Most of  these deaths are 
considered to be less senescence-related, and so to be untimely and potentially preventable. An increase in pre-
mature deaths might reflect a greater burden of  certain risk factors, e.g., smoking (lung, bronchitis and trachea 
cancer, and chronic lower respiratory diseases) and diet (diabetes). This information is potentially useful for 
prevention and treatment programs. And in fact, a reduction in tobacco consumption in Canada has resulted in 
decreased mortality due to cancer of  the lung, trachea, and bronchitis and to chronic lower respiratory diseases 
among males. Female mortality due to these causes has, however, increased since 1979, because of  a time lag in 
female patterns of  tobacco consumption relative to males (CCSSC 2010).
But the main influence on changes in life expectancies at age 65 and 85 years since 1979 has been a decrease 
in senescent deaths. As one important explanatory variable for these causes is age, the increasing number of  
people reaching higher ages should have enhanced mortality pressure due to causes that occur at very advanced 
ages. However, it has been possible to successfully reduce death rates for these diseases, as shown by the major 
decline in mortality from cardiovascular diseases. Still, even if  the senescence process can be postponed (Vaupel 
2010), it cannot be avoided, and all individuals eventually become vulnerable to multiple diseases (Horiuchi 
2007). The decrease in the main causes of  death and the increase in age at death might lead toward a greater 
diversification of  causes of  death at old ages. 
The decrease in mortality from the main causes of  death, with no apparent mortality increase in other 
specific-causes since 2000 (Appendix B), except for LBT cancer for females and accidents for both sexes, is 
likely to lead to a greater diversification of  causes of  death. Mortality due to predominant causes is decreasing, 
whereas the other causes of  death are tending to increase in relative importance—without, however, becoming 
predominant causes (Table 1). This diversification is also reflected in an increase in mortality and proportions 
for the residual group of  causes. Causes included in this group are very diverse, and none of  them accounted 
for more than 2 per cent of  the deaths in 2011. Increases in life expectancy and advancing age come with an in-
creasing vulnerability to multiple diseases, reflecting a “long-term accumulation of  unrepaired damages, leading 
to simultaneous deterioration of  many physiological functions” (Horiuchi 2007: 231). The decrease in mortality 
due to the main causes of  death, together with the increase in life expectancy, means that a diversification of  
causes of  death at old ages is likely to take place. 
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The use of  age 85 as a threshold between youngest-old and oldest-old ages may be questionable. For ex-
ample, Kannisto (1994) defined the oldest-old as people aged 80 years and higher. Using this threshold instead 
would not have changed much our results, with the exception of  Parkinson’s disease. The 80- and 85-year 
thresholds are often used, but do not reflect the dynamic process of  aging itself  (Tomassini 2005). Other, more 
dynamic indicators, such as modal age at death, might be more appropriate. 
Another potential limitation to this study is that the selected period of  1979-85 may not be the most relevant 
in terms of  comparing a previous period with the deceleration in e65 and e85 of  1985–99, because the period is 
short and may already embody some features of  the cause of  death changes of  the subsequent period.
It is also important to note that there are underlying problems with cause of  death data, which may bias the 
results ((Désesquelles and Meslé 2004; Geran et al. 2005; Meslé and Vallin 2008). After a certain age, competing 
risks between different causes of  death grow, as the chances of  dying from various diseases increase. This may 
lead to misreporting on death certificates. Some causes of  death seem to be more often declared as the primary 
cause of  death, while other causes will be considered as secondary causes (Désesquelles and Meslé 2004). This 
is the case with diabetes, for example. Diabetes seems to contribute frequently to the morbid process among the 
elderly, but is rarely stated as the primary cause of  death (Désesquelles and Meslé 2004). 
The impact of  the ICD changes is also not well understood, and may have led to greater discontinuities than 
expected (Geran et al. 2005). As shown in Appendix B, there are important discontinuities in the time trends of  
influenza and pneumonia. The drastic decrease in the death rates of  influenza and pneumonia is related to an 
important change in the rule to classify pneumonia: in ICD-10, pneumonia is now accepted as a complication 
of  any disease (WHO 2010). Pneumonia is thus considered more often as a secondary cause of  death than a 
primary one with the ICD-10 than with the ICD-9. This has led to an important decrease in the number of  
deaths due to pneumonia and to a corresponding increase in the related primary conditions (Geran et al. 2005; 
Meslé and Vallin 2008). 
Another underlying problem with the causes of  death series is changes in the perception and knowledge of  
a disease. As an example, Alzheimer’s disease was considered as a rare disease until the end of  the 1970s, but a 
better understanding of  the disease and its delineation from dementia increased the number of  diagnoses and 
deaths classified as Alzheimer’s since (Boller and Forbes 1998). Progress in perception and knowledge of  this 
disease is still ongoing. An increase in the death rates of  Alzheimer’s disease from ICD-9 to ICD-10 is observed 
as dementia in and due to Alzheimer, classify as Senile and pre-senile organic psychotic conditions in ICD-9, are 
classify to Alzheimer’s disease in ICD-10 (Geran et al. 2005; Meslé and Vallin 2008).
Although we study causes of  death trends classified with ICD-9 and ICD-10 as two different series in this 
article, these discontinuities in the trends and changes in disease knowledge could affect the results. However, de-
spite these limitations, cause of  death data still inform us regarding changes in cause of  death structure in Canada.
Conclusion
Changes in the cause of  death structure are ongoing in Canada, and the main causes of  death among people 
aged 65 years and older have been decreasing in importance since 2000. A decrease in premature deaths is ob-
served, but the main gains in life expectancy at age 65 and 85 years come from a decline in senescence-related 
causes of  death. These changes have led to a major increase in life expectancy at age 65 and 85 years. Further-
more, as a result of  the decline in the main causes of  death and the corresponding increase in life expectancy, a 
greater diversification of  causes of  death may take place at older ages. 
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Appendix A. Cause of  death contributions to change in life expectancy at age 65 
and 85 years
Table A1. Cause of death contributions to the increase in Canadian life expectancy at ages 65 and 85 years, by sex, for the 
periods 1979–85, 1985–99, and 2000–11
Causes of death
e65 e85
Males Females Males Females
1979 
–1985
1985 
–1999
2000 
–2011
1979 
–1985
1985 
–1999
2000 
–2011
1979 
–1985
1985 
–1999
2000 
–2011
1979 
–1985
1985 
–1999
2000 
–2011
Total 0.29 1.46 2.31 0.32 0.88 1.59 −0.16 0.08 0.87 0.00 0.03 0.81
Lung, bronchi, and  
trachea cancer
−0.07 0.03 0.15 −0.09 −0.19 −0.06 −0.04 −0.01 0.00 −0.01 −0.03 −0.03
Colon and rectum cancer 0.00 0.03 0.03 0.03 0.06 0.02 −0.01 0.01 0.00 0.00 0.02 0.00
Breast cancer – – – −0.04 0.04 0.06 – – – −0.01 0.00 0.01
Prostate cancer −0.02 0.02 0.13 – – – −0.01 −0.02 0.05 – – –
Other cancers 0.00 0.01 0.19 −0.02 0.02 0.14 −0.01 −0.02 0.02 −0.02 −0.03 0.03
Heart diseases 0.41 1.02 1.08 0.45 0.97 0.97 0.12 0.22 0.54 0.22 0.35 0.62
Cerebrovascular diseases 0.18 0.16 0.26 0.26 0.26 0.34 0.11 0.05 0.17 0.13 0.16 0.26
Chronic lower respiratory 
diseases
−0.07 0.09 0.18 −0.07 −0.13 0.01 −0.10 −0.03 0.10 −0.03 −0.10 −0.01
Diabetes mellitus −0.01 −0.06 0.06 −0.01 −0.01 0.09 −0.01 −0.03 0.01 −0.01 −0.04 0.03
Alzheimer’s disease −0.04 −0.01 0.03 −0.06 −0.08 0.04 −0.03 −0.04 0.01 −0.04 −0.11 0.03
Influenza and pneumonia −0.05 0.02 0.05 −0.06 −0.01 0.05 −0.09 0.00 0.07 −0.10 −0.02 0.07
Accidents 0.04 0.02 −0.01 0.05 0.01 −0.02 0.01 −0.02 −0.02 0.02 −0.02 −0.02
Nephritis, nephrotic
syndrome, and nephrosis
0.00 −0.02 0.05 −0.02 −0.01 0.04 −0.01 −0.01 0.01 −0.02 −0.01 0.00
Parkinson’s disease 0.00 −0.02 0.00 −0.01 −0.02 0.01 −0.01 −0.02 0.00 0.00 −0.02 0.00
Other diseases −0.06 0.16 0.09 −0.09 −0.03 −0.09 −0.09 0.01 −0.10 −0.13 −0.13 −0.19
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 2015g), CHMD (2015), and 
authors’ own calculations.
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Appendix B. Changes over time of  death rates by cause of  death
LBT cancer CR cancer Breast cancer
Prostate cancer Other cancers Heart d.
Cerebrovascular d. CLRD Diabetes mellitus
Alzheimer's d. Influenza/pneumonia Accidents
Nephritis Parkinson's d. Other d.
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Figure B1. Age-standardized death rates for ages 65 years and older by cause and sex, 
1979–2011, Canada.
Note: y-scales might differ from one graph to another to better visualize the time-trends; the standard 
population is the year 2000. 
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 
2015g), CHMD (2015), and authors’ own calculations.
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Appendix C. Cause-specific age variation: proportions and life table aging rates 
(LARs)
LBT cancer CR cancer Breast cancer Other cancers Heart d.
Cerebrovascular d. CLRD Diabetes mellitus Alzheimer's d. Influenza/pneumonia
Accidents Nephritis Parkinson's d. Other d.
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Figure C1. Age variation by cause of death using proportions (expressed in %) over the period 
1979–2011 and age-specific average over time (in black), observed (dot) and smoothed (line), 
Females, Canada.
Note: y-scale might differ from one graph to another to better visualize the age pattern; the trends are smoothed using  
a P-spline smoothing procedure for Poisson death counts (Camarda 2012).
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 2015g), 
CHMD (2015), and authors’ own calculations.
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Figure C2. Age variation by cause of death using proportions (expressed in %) over the period 
1979–2011 and age-specific average over time (in black), observed (dot) and smoothed (line), Males, 
Canada.
Note: y-scale might differ from one graph to another to better visualize the age pattern; the trends are smoothed using a 
P-spline smoothing procedure for Poisson death counts (Camarda 2012).
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 2015g), 
CHMD (2015) and authors’ own calculations.
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Figure C3. Life table aging rates (LARs) by cause of death over the period 1979–2011 and age-
specific average over time (in black), observed (dot) and smoothed (line), Females, Canada.
Note: The trends are smoothed using a P-spline smoothing procedure for Poisson death counts (Camarda 2012).
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 2015g), 
CHMD (2015) and authors’ own calculations.
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Figure C4. Life table aging rates (LARs) by cause of death over the period 1979–2011 and age-
specific average over time (in black), observed (dot) and smoothed (line), Males, Canada.
Note: The trends are smoothed using a P-spline smoothing procedure for Poisson death counts (Camarda 2012).
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b, 2015c, 2015d, 2015e, 2015f, 2015g), 
CHMD (2015), and authors’ own calculations.
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Appendix D. Causes of  death classification criteria
In the section “Age variation profile of  causes of  death,” we classify the different causes of  death based 
on two age profile indicators: proportions and LARs. For data availability reasons, we only have 6 age groups 
for our analysis. To help visualize the age pattern, a P-spline smoothing procedure for Poisson death counts is 
applied to our data, using the Camarda (2012) MortalitySmooth R Package. The data are interpolated and ex-
trapolated for 1-year age groups for ages from 65 to 100 years.
When looking at the proportions by age we used age 85 to separate younger-old age from oldest-old age mortal-
ity. We aim to see if  causes of  death are more prevalent before or after age 85. For some causes, as LBT cancer, 
the visualization of  the age pattern could be enough to classify the cause, i.e., if  the trends are downward, the 
proportions are higher at younger-old age, and if  the trends are upward, the proportions are higher at oldest-old 
age. However, the age pattern is sometimes bell-shaped, as in the case of  Parkinson’s disease. In order to classify 
the causes between more or less prevalent before age 85 years, we use a ratio of  the proportion of  death for the 
80–84-year age group to the proportion of  death for the 85–89-year age group. If  the ratio is higher than 1, the 
peak of  the bell-shaped distribution will occur before age 85. 
To determine if  the LARs are decreasing, increasing, or staying constant over age ranges, we applied a 
linear regression to the LARs, for the non-smoothed trends. A negative or positive slope parameter indicates 
if  the trend is decreasing or increasing. The significance level of  the slope parameter (p-value) indicates if  the 
decrease or increase is significant. If  the p-value is higher than 10 per cent, the LARs are considered to be 
constant over age.
Table D1. Classification criteria for causes of death according to their age 
variation using proportions and life table aging rates, Canada, average for 
the period 1979–2011
Proportions LARs
Cause of death
Proportion of  
age group 80–84 / 
Proportion of  
age group 85–89
Direction and 
p-value of the 
slope parameter of 
a linear regression
Female Male Female Male
Lung, bronchitis and trachea cancer 1.94 1.63 N*** N***
Colon and rectum cancer 1.20 1.23 N N**
Breast cancer 1.38 – P** –
Prostate cancer – 1.01 – N**
Other cancers 1.38 1.27 N** N**
Heart diseases 0.95 0.98 P P
Cerebrovascular diseases 0.90 0.90 N N*
Chronic lower respiratory diseases 1.24 1.04 N N***
Diabetes mellitus 1.20 1.09 N* N***
Alzheimer’s disease 0.82 0.80 N** N**
Influenza and pneumonia 0.74 0.73 P P
Accidents 0.85 0.83 P* P**
Nephritis, nephrotic syndrome
and nephropathy
0.97 0.86 N N
Parkinson’s disease 1.16 1.07 N*** N***
Other diseases 0.88 0.91 P** P**
Note: Notation for slope parameter direction: N: negative, P: positive. Notation 
for slope parameter significance level: *** p < 0.001; ** p < 0.01; * p < 0.05; p < 0.1
Sources: Canadian Vital Statistics 1979–99, Statistics Canada (2015a, 2015b,
2015c, 2015d, 2015e, 2015f, 2015g), CHMD (2015), and authors’ own calculations.
